Cardiovascular risk and glycemic control

Cheng, Alice Y.Y.; Leiter, Lawrence A.
April 2009
CMAJ: Canadian Medical Association Journal;4/28/2009, Vol. 180 Issue 9, p907
Academic Journal
In this article the authors discuss the cohort study of G. T. C. Ko and colleagues on the relation of exogenous insulin therapy to increase risk in cardiovascular disease or death of patients with type 2 diabetes. They state that the study shows the association of insulin resistance to the given clinical conditions, and assert the application of the therapy in achieving better glycemic control among patients. A brief overview of glycemic control and cardiovascular risk is also presented.


Related Articles

  • Change in HbA1c Levels between the Age of 8 Years and the Age of 12 Years in Dutch Children without Diabetes: The PIAMA Birth Cohort Study. Jansen, Hanneke; Wijga, Alet H.; Scholtens, Salome; Koppelman, Gerard H.; Postma, Dirkje S.; Brunekreef, Bert; de Jongste, Johan C.; Smit, HenriĆ«tte A.; Stolk, Ronald P. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Objective: HbA1c is associated with cardiovascular risk in persons without diabetes and cardiovascular risk accumulates over the life course. Therefore, insight in factors determining HbA1c from childhood onwards is important. We investigated (lifestyle) determinants of HbA1c at age 12 years...

  • blood Sugar LIMBO. Flower, Gillian // Alive: Canada's Natural Health & Wellness Magazine;Nov2010, Issue 337, p36 

    The article discusses the diagnosis on type 2 diabetes or non-insulin dependent diabetes. In prediabetes, the blood sugar limbo between normal readings and full-blown diabetes is turn into slight abnormalities in glucose levels measured in the fasting blood glucose (FBG) test. In addition,...

  • Link has been found between wrist size and risk of diabetes.  // Podiatry Now;Jun2011, Vol. 14 Issue 6, p14 

    The article reports a study published in the journal "Circulation" which identified an association between wrist circumference and a risk for diabetes and heart disease in overweight children.

  • Metabolic syndrome in an adolescent -- case report. Paul, Corina; Velea, I.; Tamasan, Ionela // Romanian Journal of Pediatrics;2011, Vol. 60 Issue 3, p284 

    The metabolic syndrome (MS) represents a sum of risk factors leading to the occurence of cardio-vascular diseases and diabetes mellitus (DM). Of these factors we can mention: abdominal obesity, dyslipidemia, arterial hypertension, impaired glucose tolerance. That is why the early depistation of...

  • The glucose-sensitive nanocarrier based on phenylboronic acid. Li Zhao; Liyan Wang; Guangqing Gai // Applied Mechanics & Materials;2014, Issue 680, p46 

    Recently, diabetes mellitus has become one of the most serious diseases that threat to human health and even life following cancer and cardiovascular disease. Thus, the developments of efficient insulin administration exhibit great practical significance. However, insulin, which could low blood...

  • Early Improvement Predicts Reduced Risk of Incident Diabetes and Improved Cardiovascular Risk in Prediabetic Asian Indian Men Participating in a 2-Year Lifestyle Intervention Program. Nanditha, Arun; Ram, Jagannathan; Snehalatha, Chamukuttan; Selvam, Sundaram; Priscilla, Susairaj; Samith Shetty, Ananth; Arun, Raghavan; Godsland, Ian F.; Johnston, Desmond G.; Ramachandran, Ambady // Diabetes Care;Nov2014, Vol. 37 Issue 11, p3009 

    OBJECTIVE Objectives of this ancillary analysis of a prospective, prevention study among Asian Indians with impaired glucose tolerance (IGT) were a) to quantify the reduction in incident diabetes at 24 months in participants who achieved normal glucose tolerance (NGT) at 6 months (NGT-6 m)...

  • Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome. Haidara, Mohamed; Mikhailidis, Dimitri P.; Yassin, Hanaa Z.; Dobutovic, Branislava; Smiljanic, Katarina T.; Soskic, Sanja; Mousa, Shaker A.; Rizzo, Manfredi; Isenovic, Esma R. // Current Pharmaceutical Design;11/11/2011, Vol. 17 Issue 33, p3699 

    The metabolic syndrome (MetS) is common, and its associated risk burdens of diabetes and cardiovascular disease (CVD) are a major public health problem. The hypothesis that main constituent parameters of the MetS share common pathophysiologic mechanisms provides a conceptual framework for the...

  • Metabolic syndrome and the menopause. Kaaja, Risto J. // Menopause International;Mar2008, Vol. 14 Issue 1, p21 

    The metabolic syndrome consists of a combination of risk factors that include abdominal obesity, atherogenic dyslipidaemia, hypertension and insulin resistance. It increases the risk of cardiovascular disease and type 2 diabetes. The increased risk of cardiovascular disease is higher in women...

  • Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes. Kim, Tae; Park, Man; Lee, Seong; Yang, Sae; Lee, Kwan; Nam, Moon; Park, Yong; Woo, Jeong; Kim, Young; Baik, Sei // Endocrine (1355008X);Dec2012, Vol. 42 Issue 3, p584 

    The purpose of this study is to examine the association of A1C with beta-cell dysfunction, insulin resistance, and cardiovascular risk factors in Koreans with the relatively high risk for the future development of diabetes. This cross-sectional study recruited subjects from the pre-diabetic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics